Nanobusiness News

RSS
NCCN Announces Collaboration to Conduct Anti-Cancer Drug Studies

NCCN Announces Collaboration to Conduct Anti-Cancer Drug Studies

Company Achieves Substantial Cost Savings With PLM Investment

WaferGen Signs Distribution Agreements for SmartSlide Micro-Incubation System in Europe and Asia

First and Only Anti-Cancer siRNA Drug Candidate Currently Undergoing Human Clinical Trials

The Foundry Company to Build New State-of-the-Art Manufacturing Facility

Integrated Fluidic Circuits Bring New Levels of Efficiency and Flexibility for High-Throughput Genotyping

New Toolkit from SUSS MicroTec Enables Large Area Nanoimprint Lithography

Entrepix Engages Semi Scenic UK as Distributor for Ireland and the United Kingdom

NEC Expands Capacity on New Eight-Inch Line at Wafer Fab in California

ThalesNano Forms Collaborations with Leading Universities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.